Jasmin David, a cancer sufferer, given less than a year to live, has been given the all clear of cancer after taking part in a clinical trial.
The 51 year old from Manchester, was diagnosed with an aggressive form of breast cancer in november after finding a lump above her nipple in November 2017.
In 2019, she started a trial, using an experimental medicine combined with an immunotherapy drug, at The Christie hospital.
The mother of two underwent six months of chemotherapy and a mastectomy in April 2018, followed by 15 cycles of radiotherapy which cleared her body of cancer.
But in October 2019 the cancer returned, and scans showed it had spread to her lung, lymph nodes and chest bone and she was told she had a poor prognosis.
In October 2019, she was offered a two-year trial at The Christie of an experimental medicine combined with Atezolizumab, an immunotherapy drug.
Doctors have told her she is now showing no evidence of the disease.
She said “When I was offered the trial I didn’t know if it would work for me, but I thought at least I could do something to help others and use my body for the next generation.”
“At first I had many horrible side effects including headaches and spiking temperatures, so I was in hospital over Christmas and quite poorly. Then thankfully I started to respond well to the treatment. I am here thanks to The Christie and to medical research.”
Treatment on the clinical trial will continue until December 2023.